MaaT Pharma SA (EPA:MAAT)
France
· Delayed Price · Currency is EUR 6.82
-0.16 (-2.29%)
At close: Mar 6, 2026
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €128.33 million as of March 6, 2026. Its market cap has increased by 38.27% in one year.
Market Cap
128.33M
Enterprise Value
127.70M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.82
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 128.33M, a decrease of -3.32%. That is a compound annual growth rate of -0.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 131.34M | 69.55% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adocia | 128.34M |
| Innate Pharma | 131.21M |
| ABIONYX Pharma | 115.71M |
| Sensorion | 112.63M |
| OSE Immunotherapeutics | 94.66M |
| Transgene | 233.85M |
| Cellectis | 239.40M |
| Valerio Therapeutics Société anonyme | 69.42M |